Axcella Health (NASDAQ:AXLA) Announces Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Axcella Health (NASDAQ:AXLA) posted its earnings results on Monday. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.64) by ($0.04), MarketWatch Earnings reports.

Shares of NASDAQ AXLA opened at $2.95 on Wednesday. The stock’s 50-day moving average is $3.93 and its two-hundred day moving average is $4.60. The company has a debt-to-equity ratio of 0.33, a current ratio of 11.75 and a quick ratio of 11.75. Axcella Health has a 1-year low of $2.25 and a 1-year high of $15.99. The company has a market cap of $62.41 million and a price-to-earnings ratio of -0.61.

In related news, Director David R. Epstein purchased 12,800 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were bought at an average price of $3.65 per share, for a total transaction of $46,720.00. Following the acquisition, the director now directly owns 66,098 shares in the company, valued at $241,257.70. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders have acquired 17,465 shares of company stock worth $69,689.

Separately, Zacks Investment Research raised Axcella Health from a “hold” rating to a “buy” rating and set a $3.00 target price on the stock in a research note on Tuesday. Five equities research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and a consensus target price of $17.25.

About Axcella Health

There is no company description available for Axcella Health Inc

Recommended Story: What is a growth and income fund?

Receive News & Ratings for Axcella Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcella Health and related companies with MarketBeat.com's FREE daily email newsletter.